美国疼痛和神经科学学会关于使用60天周围神经刺激疗法的共识指南。一个神经元生活指南项目。

IF 2.5 3区医学 Q2 CLINICAL NEUROLOGY

Journal of Pain Research Pub Date : 2025-06-24 eCollection Date: 2025-01-01 DOI:10.2147/JPR.S521788

Benjamin Gill, Cody Tidwell, Jonathan M Hagedorn, Alexandra M Moreira, Marco Lawandy, Benjamin Boyett, Justin Schappell, Usman Latif, Scott Pritzlaff, Ioannis Skaribas, Hemant Kalia, Samir Sheth, Maricela Schnur, Sean Li, Denise Lester, Trevor Ellico, Ramana Naidu, David Russo, Christopher Massey, Einar Ottestad, Kevin Vorenkamp, Henry Vucetic, Matthew J Pingree, David Abejón, Mehul J Desai, David Dickerson, Amitabh Gulati, Dawood Sayed, Timothy R Deer

{"title":"美国疼痛和神经科学学会关于使用60天周围神经刺激疗法的共识指南。一个神经元生活指南项目。","authors":"Benjamin Gill, Cody Tidwell, Jonathan M Hagedorn, Alexandra M Moreira, Marco Lawandy, Benjamin Boyett, Justin Schappell, Usman Latif, Scott Pritzlaff, Ioannis Skaribas, Hemant Kalia, Samir Sheth, Maricela Schnur, Sean Li, Denise Lester, Trevor Ellico, Ramana Naidu, David Russo, Christopher Massey, Einar Ottestad, Kevin Vorenkamp, Henry Vucetic, Matthew J Pingree, David Abejón, Mehul J Desai, David Dickerson, Amitabh Gulati, Dawood Sayed, Timothy R Deer","doi":"10.2147/JPR.S521788","DOIUrl":null,"url":null,"abstract":"Peripheral nerve stimulation (PNS) has evolved with various applications and durations of therapy. In recent years, extensive data has been developed on a 60-day treatment using a novel approach. Confusion exists on the use of a trial therapy, a permanent implant, and a 60-day duration treatment. The American Society of Pain and Neuroscience (ASPN) seeks to clarify the literature associated with this neuromodulation approach. A diverse group of experts was nominated to provide opinions and guidance based on evidence-graded assessment and clinical knowledge. This guidance is the first to specifically assess the clinical use of 60-day PNS and best medical practice.","PeriodicalId":16661,"journal":{"name":"Journal of Pain Research","volume":"18 ","pages":"3117-3139"},"PeriodicalIF":2.5000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12206896/pdf/","citationCount":"0","resultStr":"{\"title\":\"Consensus Guidelines from the American Society of Pain and Neuroscience for the Use of 60-Day Peripheral Nerve Stimulation Therapy. A NEURON Living Guideline Project.\",\"authors\":\"Benjamin Gill, Cody Tidwell, Jonathan M Hagedorn, Alexandra M Moreira, Marco Lawandy, Benjamin Boyett, Justin Schappell, Usman Latif, Scott Pritzlaff, Ioannis Skaribas, Hemant Kalia, Samir Sheth, Maricela Schnur, Sean Li, Denise Lester, Trevor Ellico, Ramana Naidu, David Russo, Christopher Massey, Einar Ottestad, Kevin Vorenkamp, Henry Vucetic, Matthew J Pingree, David Abejón, Mehul J Desai, David Dickerson, Amitabh Gulati, Dawood Sayed, Timothy R Deer\",\"doi\":\"10.2147/JPR.S521788\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Peripheral nerve stimulation (PNS) has evolved with various applications and durations of therapy. In recent years, extensive data has been developed on a 60-day treatment using a novel approach. Confusion exists on the use of a trial therapy, a permanent implant, and a 60-day duration treatment. The American Society of Pain and Neuroscience (ASPN) seeks to clarify the literature associated with this neuromodulation approach. A diverse group of experts was nominated to provide opinions and guidance based on evidence-graded assessment and clinical knowledge. This guidance is the first to specifically assess the clinical use of 60-day PNS and best medical practice.\",\"PeriodicalId\":16661,\"journal\":{\"name\":\"Journal of Pain Research\",\"volume\":\"18 \",\"pages\":\"3117-3139\"},\"PeriodicalIF\":2.5000,\"publicationDate\":\"2025-06-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12206896/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pain Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2147/JPR.S521788\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pain Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/JPR.S521788","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

摘要

周围神经刺激（PNS）随着治疗的应用和持续时间的不同而发展。近年来，使用一种新方法进行60天治疗的大量数据得到了发展。在使用试验疗法、永久植入和60天持续治疗方面存在混淆。美国疼痛与神经科学学会（ASPN）试图澄清与这种神经调节方法相关的文献。一个多元化的专家小组被提名，根据证据分级评估和临床知识提供意见和指导。本指南是第一个专门评估60天PNS临床应用和最佳医疗实践的指南。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Consensus Guidelines from the American Society of Pain and Neuroscience for the Use of 60-Day Peripheral Nerve Stimulation Therapy. A NEURON Living Guideline Project.

Peripheral nerve stimulation (PNS) has evolved with various applications and durations of therapy. In recent years, extensive data has been developed on a 60-day treatment using a novel approach. Confusion exists on the use of a trial therapy, a permanent implant, and a 60-day duration treatment. The American Society of Pain and Neuroscience (ASPN) seeks to clarify the literature associated with this neuromodulation approach. A diverse group of experts was nominated to provide opinions and guidance based on evidence-graded assessment and clinical knowledge. This guidance is the first to specifically assess the clinical use of 60-day PNS and best medical practice.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Pain Research CLINICAL NEUROLOGY-

CiteScore

4.50

自引率

3.70%

发文量

411

审稿时长

16 weeks

期刊介绍： Journal of Pain Research is an international, peer-reviewed, open access journal that welcomes laboratory and clinical findings in the fields of pain research and the prevention and management of pain. Original research, reviews, symposium reports, hypothesis formation and commentaries are all considered for publication. Additionally, the journal now welcomes the submission of pain-policy-related editorials and commentaries, particularly in regard to ethical, regulatory, forensic, and other legal issues in pain medicine, and to the education of pain practitioners and researchers.